Clinical microbiology is a science that studies the morphology, structure, classification, and laws of life of microorganisms. It is one of the foundations of clinical medicine, guiding the diagnosis, treatment, and prevention of infectious diseases. The branch of medical science is concerned with the prevention of infections caused by pathogens to human beings. Clinical microbiology studies about the structure, classification, and activities of microorganisms that cause viral hepatitis, caries and periodontal disease, sexually transmitted diseases, etc. are caused by pathogenic organisms. The role of clinical microbiology is to provide diagnostic information to patients for the identification of infections caused by viruses, fungi, or parasites.
The global Clinical Microbiology market expected to bolster the market growth at an enormous CAGR in the forecast period from 2020-2027. Continuous technological advancements in the field of infectious disease diagnosis, rising cases of infectious diseases, and the emerging outbreak of virus infection are fueling the market of clinical microbiology. However, factors such as reimbursement concerns and government regulatory scenarios are restraining the growth of this market to a certain extent.
Moreover, the rising development of technology has helped the healthcare sector to diagnose the diseases at a faster rate. The increasing adoption of artificial intelligence helps in streamlining the clinical microbiology functions and solutions at every step.
Therefore, it helps in diagnose infections quickly and accurately for better patient care with powerful automated technologies and non-invasive equipment. It is coupled with a comprehensive line of media and clinical diagnostic products. Thus, the adoption of automation in the healthcare industry will provide adequate and better results in the treatment of diseases.
In addition to it, where automation meets accuracy, it improves confidentiality and identify bacterial pathogens and detect emerging antibiotic resistance. Automation not only provide the time-saving benefits but also optimize patient care, support antimicrobial stewardship, and improve lab efficiency.
The outbreak of various infectious diseases like Ebola, Coronavirus, Influenza, etc. are causing the contagious infection, which is propelling the market demand for the clinical microbiology. Clinical microbiology helps in diagnosis the treatment of various infectious diseases caused by parasites and viruses.
The advanced technologies in the healthcare sector has improved the health facilities of the people. The non-invasive instrument and conventional diagnostic and clinical labs are enhancing the functions of medical science and help in overcoming the epidemic situations.
Based on the product, the global Clinical Microbiology market segmented into Instrument, Analyzer, Reagent. The instruments product segment holds the largest share of the market. However, the reagents product segment expected to grow at a higher rate during the forecast period from 2020-2027. The growth of the reagents segment attributed to the high prevalence of infectious diseases across major markets, the growing instrument sales and trend of reagent rental agreements along with rising number of life science researches taking place in the field of pathogen-specific reagents.
Based on Application, the global Clinical Microbiology market classified into Pharmaceutical, Clinical, Food Testing, Energy, Chemical and Material Manufacturing, Environmental. The clinical segment has fueled the market share of the global clinical microbiology market. It is mainly owing to the rising demand for conventional clinical laboratories for the testing of new drugs like qPCR and other technologies. Moreover, the investment made by the government in R&D for the diagnosis of various infections caused by pathogens will propel the market demand for the global clinical microbiology market.
Based on the disease area, the global Clinical Microbiology market segmented into Bloodstream Infections, Respiratory Diseases, Gastrointestinal Diseases, Urinary Tract Infections (UTIs), Sexually Transmitted Diseases, Periodontal Diseases, Other Diseases. The respiratory diseases dominate the larger market share in the global clinical microbiology market. It is majorly in the wake of the rising geriatric population, the increasing level of pollution, and the outbreak of various viruses caused by the microorganism. The viruses majorly affect the low immune system of people and caused respiratory problems. Coronavirus is one of the illnesses that firstly affect the respiratory system of the patient and then create the failure of other body parts.
Based on the end-users, the global Clinical Microbiology market distributed into Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes. Custom labs have the largest market share in the global clinical microbiology market. The main factors driving growth in this area include the development of various custom labs used to test new medicines and finding the treatment of the virus and other infections caused by a microorganism. Therefore, the demand for custom labs is bolstering the market of clinical microbiology.
Based on geography, the global Clinical Microbiology market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The Asia Pacific expected to grow significantly owing to growing number of hospitals and clinical diagnostic laboratories in developing APAC countries; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and the rising incidence and prevalence of infectious diseases in the region.
Companies such as bioMérieux SA, Danaher Corporation, Becton, Dickinson and Company, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Bruker Corporation, Hologic, Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Merck KGaA, Shimadzu Corporation, 3M Company, and Neogen Corporation and others are key players in the global clinical microbiology market.
By Disease Areas